LY6K and ovarian cancer: High Ly6K mRNA expression in ovarian cancer was significantly correlated with poor five-year overall survival (low Ly6K, n=96; high Ly6K, n=97; HR=1.3, p=0.0008) shown by PROGgeneV2 (Table S4, Figure 4C).